Market Research Blog

Respiratory syncytial virus (RSV) is a common virus that causes respiratory infection. The virus infects lungs and respiratory passage. RSV infection is common among adults who experience symptoms like mild cold however in infants and older people the infection can be very serious.

RSV is the most common cause of bronchiolitis and pneumonia among infants. RSV infection is limited to the respiratory tract. The virus inoculates in the lower respiratory tract and spreads into the respiratory system through cell to cell transfer in syncytia.

RSV infection has very high incidence rate. According to the Centers for Disease Control and Prevention (CDC), almost all children get RSV infection by the age of 2 years. Moreover the Respiratory syncytial virus spreads very quickly through cough, sneeze and touching the infected surfaces which delivers the virus into the host body.

The recovery period for RSV infection is around 1 to 2 weeks among infants, the virus still remains in the body and can spread easily to another person. Owing to high incidence rate, the market for pediatric syncytial virus infection is expected to witness robust growth over the forecast period.

Pediatric Respiratory Syncytial Virus Infection Market: Drivers and Restraints

Growing incidence of RSV among children is expected to increase demand for RSV infection treatment products. Rise in the birth rate is expected to propel demand for RSV treatment products over the forecast period. According to the United Nations, Department of Economic and Social Affairs, the global population is expected to reach 8.5 billion by 2030.

This increase in the baby boomer population is expected to add to the patient pool of the RSP virus and thus in turn increase demand for RSV infection treatment over the forecast period. RSV infection can occur at any age however the infection rate among children varies as compared to adults.

Among infants and children, nearly 25 out of every 40 children suffering from RSV infection, exhibit signs of bronchiolitis or pneumonia. Owing to severity of the infection the awareness among public regarding the RSV infection is growing which in turn is expected to boost demand for respiratory syncytial virus infection treatment.

Increase in the risk of acquiring RSV among children is associated with the community settings like attending school, exposure to environmental pollutants etc. with changing social dynamic structure the incidence rate of RSV infection is expected to grow rapidly over the forecast period. However absence of definitive treatment, side effects and limited efficacy of the drugs available in the market and dependency in symptom based treatment in several cases is expected to hamper revenue growth of the pediatric respiratory syncytial virus infection market over the forecast period.

Request a Sample:

https://www.futuremarketinsights.com/reports/sample/rep-gb-2345

Pediatric Respiratory Syncytial Virus Infection Market: Overview

The global market for pediatric respiratory syncytial virus infection is expected to witness robust growth owing to increasing incidence rate of the RSV infection and growth in the birth rate.

Pediatric Respiratory Syncytial Virus Infection Market: Region – wise Outlook

Globally the pediatric respiratory syncytial virus infection market is segmented into seven key regions: North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan (APEJ), Japan and Middle East and Africa (MEA). Globally RSV is responsible for nearly 18% of the total child deaths.

North America and Western Europe are expected to be the leading markets in the global pediatric respiratory syncytial virus infection market. High awareness and easy available diagnostic tests are expected to boost demand for RSV infection treatment products in these regions.

Japan and APEJ are expected to follow next in terms of demand for the treatment of pediatric respiratory syncytial virus infection market. Eastern Europe, Latin America and MEA markets are also expected to witness above average growth over the forecast period. Absence of population based studies in developing countries is a major challenge in assessment of RSV related infections in these countries.

Pediatric Respiratory Syncytial Virus Infection Market: Participants

Some players in the global pediatric syncytial virus infection market are Ablynx NV, Aridis Pharmaceuticals, Inc., Artificial Cell Technologies, Inc. is conducting studies for development of vaccine against RSV. The company’s vaccines is into pre – clinical development and preparing for IND filing to conduct phase 1 trials.

Astellas Pharma Inc. entered into strategic partnership with ClearPath Development company for building a vaccine portfolio for Respiratory Syncytial Virus, AstraZeneca is conducting observational studies of Respiratory Syncytial Virus Hospitalizations among U.S. infants. Bavarian Nordic., a biotechnology company is building a antibody based treatment against RSV, which is currently into phase 2 clinical trials.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types and technology.

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-2345

The report covers exhaustive analysis on

• Market Segments
• Market Dynamics
• Market Size
• Current Trends/Issues/Challenges
• Competition & Companies involved
• Value Chain

Regional analysis includes

• North America (U.S., Canada)
• Latin America (Mexico. Brazil)
• Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
• Eastern Europe (Poland, Russia)
• APEJ (China, India, ASEAN, Australia & New Zealand)
• Japan
• Middle East and Africa (GCC, S. Africa, N. Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/reports/brochure/rep-gb-2345

Pediatric Respiratory Syncytial Virus Infection Market: Segmentation

By Therapy

• Bronchodilators
• Alpha agonists
• Ribavirin

By Distribution Channel

• Hospital Pharmacies
• Drug Stores
• Retail Pharmacies
• Clinics

About Future Market Insights, Inc.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact Us:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

Molecular biomarkers are molecules which can be used as indicators for normal biological processes, pathogenic processes and body’s response to pharmacological processes.

Molecular biomarkers for cancer detection provide information of an individual’s likeliness to develop cancer, provide information on the type of cancer, provide information on optimal drugs that can be used for the treatment of cancer, whether the chances of cancer returning after going into remission persist, etc.

Cancer detection molecular biomarkers are usually made up of proteins, however, in recent years the information related to cancer biomarkers has increased rapidly along with developments in gene expression technology has led to the development of DNA-based molecular biomarkers which can provide more specific information and early detection of cancer.

With the growing incidence cancer worldwide and rising economic burden caused by cancer is expected to increase demand for early detection of cancer.

Molecular Biomarkers for Cancer Detection Market: Drivers and Restraints 

Rising incidence of cancer globally is expected to boost the molecular biomarkers for cancer detection market over the forecast period. As per the CDC (Centers for Disease Control and Prevention) by 2025, 19.3 million cases of cancer cases are expected to be diagnosed each year which in turn is supposed to increase demand for early detection of cancer.

Development of molecular biomarkers – blood-based strategies to detect and monitor cancer is expected to boost demand for such biomarkers over the forecast period. The paradigm shift towards personalized medicine for treatment of cancer is expected to increase demand for cancer detection biomarkers as manufacturing personalized medicine depends on the pharmacological diagnosis of cancer.

Collaborations between research centers and manufacturers over the forecast period is expected to boost the molecular biomarkers for cancer detection market. However, a high cost of biomarkers and failure of products in R&D pipeline is expected to hamper the market growth.

As biomarkers are mostly derived from human tissue negative opinion form patients is expected to slow revenue growth of the molecular biomarkers for cancer detection.

The low shelf life of biomarkers is also a critical factor which may reduce adoption rate however with the development of biomarkers with increased shelf life by the manufacturers over the forecast period the demand for molecular biomarkers for cancer detection is expected to gain traction.

Request a Sample:

https://www.futuremarketinsights.com/reports/sample/rep-gb-1788

Molecular Biomarkers for Cancer Detection Market: Region – Wise Outlook

Regionally, North America is expected to be the dominant market. Rising incidence of cancer and high adoption of biomarkers is expected to boost the demand for molecular biomarkers for cancer detection. Western Europe is expected to follow next in adoption of molecular biomarkers for cancer detection.

Increasing research funding for development of novel biomarkers and presence of key players in the North America and Western Europe is expected to create high growth opportunities for biomarker manufacturers in these regions.

APEJ (Asia-Pacific excluding Japan) is expected to be next followed by North America and Western Europe owing to increasing demand for cancer diagnostics in India, Australia, and China.

Japan is expected to witness the high adoption of molecular biomarkers owing to increasing R&D investment in cancer-related research form the government and local clinical research organizations.

Latin America and MEA regions are expected to follow in line demand for molecular biomarkers for cancer detection owing to changing global trend for cancer detection.

Molecular Biomarkers for Cancer Detection Market: Key Players

Some key players in the molecular biomarkers for cancer detection are Abbott Laboratories, Agilent Technologies, Roche Diagnostics, Ltd., Qiagen N.V., Thermo Fisher Scientific, Inc., Becton Dickenson & Company, Merck & Co, Inc.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data.

It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-1788

The report covers exhaustive analysis on

• Market Segments
• Market Dynamics
• Market Size
• Current Trends/Issues/Challenges
• Competition & Companies involved
• Value Chain

Regional analysis includes

• North America (U.S., Canada)
• Latin America (Mexico. Brazil)
• Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
• Eastern Europe (Poland, Russia)
• APEJ (China, India, ASEAN, Australia & New Zealand)
• Japan
• Middle East and Africa (GCC, S. Africa, N. Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain.

The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/reports/brochure/rep-gb-1788

Molecular Biomarkers for Cancer Detection Market: Segmentation

The global biomarkers for cancer detection market are segmented into three segments, by cancer/tumor type, by end user and by region.

Segmentation by cancer/tumor type

• Breast cancer
• Lung cancer
• Prostate cancer
• Colorectal cancer
• Cervical cancer
• Others

Segmentation by end user

• Hospitals
• Specialty clinics
• Diagnostic centers

About Future Market Insights, Inc.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact Us:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

Heart failure is one of the most common cause of deaths worldwide, it is a condition when the heart cannot pump blood properly throughout the body. In most of the cases the left ventricle gets affected but sometimes the right ventricle gets affected and the heart cannot pump oxygen rich blood to the lungs.

Ventricle assist devices are mechanical pumps which support the functioning of the heart in individuals who have weak heart. There are two types of heart failure one is diastolic heart failure and the other systolic heart failure.

The major symptoms of heart failure are fatigue, irregular heart rhythm, blood pressure, heart valve functioning is affected, shortness of breath and fluid retention. Most of the above symptoms can be stabilized by the use of medication but in some cases ventricle assist devices have to be used depending upon the condition of the patient.

A ventricle assist device comprises of a small tubes transferring blood out of heart and into the pump, the heart pump is connected to a control unit, which monitors the functioning of the ventricle assist device. Recent research has shown that continuous flow ventricle assist devices are more effective as they reduce the hospitalization and improve survival rate of patients suffering from heart failure.

The different types of ventricle assist devices available in the market, left ventricle support, right ventricle support and bi-ventricle support.

The ventricle assist devices are used for short-term period for individuals recovering from myocardial infraction or individuals recovering from cardiac surgery, and for long term use in individuals suffering from total heart failure.

Request a Sample:

https://www.futuremarketinsights.com/reports/sample/rep-gb-2273

Ventricle devices are generally used as bridge to transplant, bridge to decision and bridge to recovery for an individual who is suffering from Class III & Class IV heart failure. Ventricle assist devices are generally implantable and transcutaneous depending on the individual heart condition.

Transcutaneous ventricle assist devices have the control unit installed outside the body and the pump placed inside the body whereas implantable ventricle assist devices are generally used for people waiting for heart transplant.

Ventricle assist devices are generally categorized as Pulsatile and Non Pulsatile devices. Pulsatile devices were the first generation devices, whereas non pulsatile devices have a continuous flow as they allow the blood to move forward in a systemic circulation. In a non-pulsatile ventricle assist device all the parameters are displayed on the console or the control unit.

Some of the common ventricle assist devices in the market are Thoratec VAD, Heart Mate and Jarvik 2000.Ventricle assist devices although have great benefits but some time they may give rise to certain complication like bleeding, infection, thrombosis, device malfunctioning and hemolysis.

When both the ventricle stop functioning or the entire heart fails, bi-ventricle assist devices are used and Total Artificial Heart is implanted. The rapid advancement in ventricle assist device technology has limited the TAH (Total Artificial Heart) development as majority of the heart failure can be controlled by using ventricle assist devices.

At present the only TAH approved by the FDA is the Cardio West TAH by Syncardia System, which is a pneumatically powered dual chamber device.

Ventricle Assist Device Market: Drivers and Restraints

The global market for ventricle assist devices is expected to be driven by the advancement in technology and increasing prevalence of Class III & Class IV heart failure, increase in geriatric population, better reimbursement reforms are some factors anticipated to fuel growth of global ventricle assist devices market within the forecast period of 2016-2026.

However the high cost certain complication which may arise after or during the implant and development of the total artificial heart can be the restraint for the growth of this market.

Ventricle Assist Device Market: Overview

Cost-effectiveness of ventricle assist devices and ongoing researches on improving quality of care for continence would create an attractive growth opportunities for the ventricle assist device market. The hospitals end user segment is expected to hold the highest market share in global market for ventricle assist devices.

A new generation of ventricle assist devices have been approved by the FDA which are more efficient in increasing the survival rate of individuals suffering from heart failure. These devices are much small smaller in size and much more efficient in restoring the functioning of the heart.

These are centrifugal continuous flow pumps suspended through magnetic or hydrodynamic levitation in blood flow path, this levitation mechanism theoretically increases the device durability and reliability as there is no friction and heat generation component contact. The third generation left ventricle assist devices are more used in Europe.

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-2273

Ventricle Assist Device Market: Regional Overview

Region wise, the global ventricle assist device market is classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. North America dominated the global market for ventricle assist devices because of better reimbursement policies for diagnostic procedures. Europe dominates the market for the third generation ventricle assist devices.

Ventricle Assist Device Market: Key Players

Some of the key players in global ventricle assist device market are SynCardia System Inc., St. Jude Medical, Berlin Heart, Heart Ware International, Jarvik Heart Inc. Abiomed, CardiacAssist Inc., and Reliant Heart Inc.

The report covers exhaustive analysis on

• Market Segments
• Market Dynamics
• Market Size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies involved
• Technology
• Value Chain

Regional analysis includes

• North America (U.S., Canada)
• Latin America (Mexico, Brazil)
• Western Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX)
• Eastern Europe (Russia, Poland, Rest Of Eastern Europe)
• Asia Pacific Excluding Japan (China, India, ASEAN, Australia & New Zealand)
• Japan
• Middle East and Africa (GCC, S. Africa, N. Africa, Rest Of MEA)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/reports/brochure/rep-gb-2273

Ventricle Assist Device Market: Segmentation

The global Ventricle assist device market is classified on the basis of product type, modality, indication, end user and geography.

Based on modality, the global Ventricle assist device market is segmented into the following:

• Transcutaneous Ventricle Assist Devices
• Implantable Ventricle Assist Devices

Based on product type, the global Ventricle Assist device market is segmented into the following:

• LVAD (Left Ventricle Assist Devices)
• RVAD (Right Ventricle Assist Devices)
• Bi-VAD (Bi-Ventricle Assist Devices)
• TAH (Total Artificial Heart)

Based on indication, the global ventricle assist device market is segmented into the following:

• Bridge to Recovery
• Bridge to Transplant
• Bridge to Therapy

Based on end user, the global ventricle assist device market is segmented into the following:

• Hospitals
• Specialized Cardiac Clinics
• Ambulatory Surgical Centers

About Future Market Insights, Inc.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact Us:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

‘Stress’ is a word heard all too much in the fast paced, hectic lives that we all lead today. But what exactly is stress? In simple terms, it’s just a way for the body to respond to any kind of threat, either real or perceived. Stress hormones like adrenalin and cortisol are released by the nervous system, which prepare the body to either fight or take flight! A moderate amount of stress is actually good, contradictory as that may seem.

It keeps you alert at work, focused on winning a game or even motivates you to study when a crucial exam is approaching! However, when a person’s physical and mental well-being is threatened by their high stress levels, medication of some sort is required.

That’s where the stress test equipment market comes into picture. A stress test helps find out if a person has arrhythmia, if breathing problems faced are heart-related, how much they should exercise, or even to see if heart disease treatments are working. It is done by making a person walk on a treadmill to measure the heart rate, breathing, BP and the electrocardiogram.

Stress Tests Equipment market: Drivers

‘Prevention is better than cure’ is one of the most famous proverbs that cannot be more apt anywhere but in the drivers of the stress test equipment market. An aging population in the developed world, increasing prevalence of cardiac and breathing disorders due to rising pollution levels in the developing world all contribute to the growth of the stress test equipment market.

Even new hospitals constructed would definitely be responsible for increase in the demand. In 2014, more than a third of all deaths worldwide could be linked to cardiovascular diseases as per an estimate by the American Heart Association. Increasing awareness by the general public and also various government initiatives to educate people about various treatments available is expected to only grow the demand for this product and the whole market.

Request a Sample:

https://www.futuremarketinsights.com/reports/sample/rep-gb-2256

Stress Tests Equipment market: Restraints

It would seem that all factors point to an increasing level of stress and thus an ever-growing market to check or control it. However, the stress test equipment market also has a few restraints challenging its growth which must be mentioned. Acts such as the Affordable Care Act, encourages the healthcare sector to provide cost-effective treatment to their patients.

This also makes them seriously reconsider investing in expensive stress test equipment. This becomes a much larger problem in the developing world, since the funds available with hospitals or the private sector there is much lower.

Stress Tests Equipment market: Key regions

The Stress Tests Equipment market key regions correspond to the various geographic divisions i.e. North America, Europe, Asia- Pacific, Latin America, Middle East and North Africa (MENA) and the rest of the world (RoW). North America is currently the largest market because they have the most medical professionals and also some of the highest stress levels (hence greater awareness of the tests).

However, Asia- Pacific and in particular China is fast catching up in this category. Rising levels of air pollution have increased the occurrence of both respiratory and cardiovascular issues in this fast growing region, fuelling the long-term growth prospects of the stress test equipment market.

Stress Tests Equipment market:Key Market Players 

Thermo Fisher Scientific Ltd., Philips healthcare, Cardinal Health, Care Medical Ltd., Cosmed Medical, Cardiac Science Corporation and GE Healthcare are some of the stress tests equipment market key market players. Most of the companies are based in North America, since it is currently the largest stress test equipment market.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, types and applications.

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-2256

The report covers exhaustive analysis on

• Market Segments
• Market Dynamics
• Market Size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies involved
• Technology
• Value Chain

Regional analysis includes

• North America (U.S., Canada)
• Latin America (Mexico. Brazil)
• Western Europe (Germany, Italy, France, U.K, Spain)
• Eastern Europe (Poland, Russia)
• Asia Pacific (China, India, ASEAN, Australia & New Zealand)
• Japan
• Middle East and Africa (GCC, S. Africa, N. Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/reports/brochure/rep-gb-2256

About Future Market Insights, Inc.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact Us:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

A billion dollar medical equipment industry is lurking under the shadow of the healthcare industry which is evolving very fast. Several big international players are infusing massive funds into research and development to change the entire landscape of the medical tools and equipment industry.

Reachers are mostly made of aluminum and comes as an aid for people who have problem in bending or stretching. They are available in a gamut of designs and they are portable and can be carried along. They are extremely helpful for adult citizens and also for patients who are suffering with any kind of knee or back problem. Even they come to the rescue of pregnant women, as it bars them from bending or stretching.

The global reachers market is massive and it is mopping up a massive revenue from the global market every passing year. The reachers market feeds on the global healthcare ecosystem which is significantly with passing time.

The exuberant growth of the healthcare industry is also accosting the development of the medical equipment industry and thus it is also expanding the global reachers market. United States is one of the major manufacturers and exporters of medical tools and it supplies its medial apparatus to countries like Germany, Japan, Australia, Mexico and man more.

The country spends massive sum of money on the development of new medical devices an amount is close to 7.3 billion. This is a big push for the entire reachers market. Apart from U.S. the local market of China and India are steadily rising.  The export and the import markets are thriving in these regions of Asia.

Reachers market: Drivers

The reachers market is clinging on to the growth of the elderly population. They are also reaping their profits from the surge in the healthcare device markets. Apart from this, the reachers market can witness a considerable hike in the countries which are over populated with expecting women.

According to statistics countries in the African region has highest birth rates. Nigeria is topping the chart with 46.12 percent followed by Mali at 45 percent and a slew of other African countries. As per the report published by UN (United Nations), the elderly population of the world will reach its cusp within the coming few years. This will again beef up the prospects for the reachers market.

Request a Sample:

https://www.futuremarketinsights.com/reports/sample/rep-gb-2244

Reachers market: Restraints

Though the development of the reachers market is dependent upon several catalysts but there are multiple blockades which are blocking the advancement of this industry globally. One of the biggest restraint for this industry is the awareness about this tool in the developing markets like India and China, Mexico, Brazil or any other developing nation where the public healthcare system is maimed by foul healthcare strategies.

The government’s apathy towards the research and development of the medical device industry which is spread in these Asian, African or Lain American countries.  Developing markets, low public awareness levels, local traders, cheap cloning of several medical tools and devices like reachers are is barricading the headway of the reachers market in these locations of the world.

Reachers market: Key Regions

As discussed earlier the medical device and reachers manufacturers are mostly located in the U.S. and U.K. and they are exporting heavily to the third world nations of the world. They are catering their services to the countries like Japan, China, India, and spreading their operations in these markets massively.

The local manufacturers of China and India are also rising the chart with their developing healthcare market. The neighbouring countries like Sri Lanka and Bangladesh and Bhutan are some of the prospective clients of the reachers market based in this parts of the world.

Reachers market: Key Players

The medical device manufacturing industry is growing at an approximate rate of 9 percent and it has earned a revenue of close to 10 billion. U.S. is also dominating a considerable amount of the international market. Companies like DeVilbliss health care in U.S. and Nova from L.A., and much more are presently exporting high-end reachers to the international markets.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, types and applications.

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-2244

The report covers exhaustive analysis on

• Market Segments
• Market Dynamics
• Market Size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies involved
• Technology
• Value Chain

Regional analysis includes

• North America (U.S., Canada)
• Latin America (Mexico. Brazil)
• Western Europe (Germany, Italy, France, U.K, Spain)
• Eastern Europe (Poland, Russia)
• Asia Pacific (China, India, ASEAN, Australia & New Zealand)
• Japan
• Middle East and Africa (GCC, S. Africa, N. Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/reports/brochure/rep-gb-2244

About Future Market Insights, Inc.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact Us:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

Spinal devices are used in spinal cord injury in order to regain the loss of body sensation such as mobility or feeling. The spinal cord injury is different from back injuries and patient suffers from major disorders such as ruptured disks, spinal stenosis or pinched nerves.

The global market of spinal devices is expected to grow steadily due to increase in aging among population, incidences of spinal diseases and advances in technology. The global spinal devices market is anticipated to be driven by product innovations, pipeline methodologies, FDA approvals and growing number of spinal surgeries.

According to the Society of Neurointerventional Surgery, neurointervention is an approach for treatment that occurs within the vessels of brain or with the spinal cavity. It is gaining high traction among neuro-specialist due to minimal invasive technique and higher success rate ratio as compared to the conventional clipping method.

In October 2016, the U.S. Food & Drug Administration approved the pedicle screw spinal system in order to provide immobilization and stabilization of spinal segments in thoracic, lumbar, and sacral spine as an adjunct fusion in treatment of degenerative disc diseases and spondylolisthesis.

Few surgeries, such as minimally invasive spine surgery aims to stabilize the vertebral bones and spinal joints which relieve pressure applied to spinal nerves. The surgery induces the placement of instrument, such as rods and screws to stabilize the spine.

Various techniques have been deployed for MIS surgery such as discetomy, spinal decompression, MIS (Minimally Invasive Surgery) TLIF (Transforaminal lumbar interbody fusion) which uses tubular retractor, portals to implant the devices, rods, screws in order to stabilize the spinal cord and improve the mobility.

Spinal Device Market: Drivers and Restraints

The global market for spinal device is expected to be driven by the advancement in technology and increase in number of spinal surgery, aging among population, etc. According to the National Spinal Cord Injury Association Resource Center, around 250,000 – 400,000 individuals were living with Spinal Cord Injury or Spinal Dysfunction, out of which 82% were males and remaining 18% were females.

The causes of spinal cord injury were motor vehicle accidents (44%), act of violence (24%), sudden falls (22%), sports (8%) and others (2%). Moreover, increased use of spinal devices in elderly patients and arthritis patients are some factors anticipated to fuel growth of the global spinal device market within the forecast period of 2016-2026.

However, therapeutics and ongoing drug researches to overcome the pain of surgery could pose a threat for the growth of the global spinal device market during the forecast period.

Request a Sample:

https://www.futuremarketinsights.com/reports/sample/rep-gb-2236

Spinal Device Market: Overview

Increase in the production number of spinal implants, spinal surgery and ongoing researches on improving quality of care for continence is expected to create an attractive growth opportunity for the global spinal device market through 2026.

According to the National Spinal Cord Injury Association Resource Center, 32 spinal injuries per Mn population or 7800 injuries occur in the U.S. each year. The hospitals end user segment is expected to hold the highest market share in global market for spinal devices during 2016-2026.

Spinal Device Market: Regional Overview

Region wise, the global spinal device market is classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan, Middle East & Africa. North America dominated the global market for spinal devices due to the availability of reimbursement policies as well as healthcare infrastructure.

Increasing number of spinal injury incidences through accidents, ageing and improved lifestyle among population are few trends which are expected to fuel the growth of the spinal device market in APEJ region through 2026.

Spinal Device Market: Key Players

Some of the key players in the global spinal device market include Stryker, Vertiflex Inc., Smith & Nephew, Siemens Healthcare GmbH, RTI Surgical, Orthofix Holdings, Inc., Medtronic, Zimmer Inc., CONMED, Aspen Medical Products and others.

Most of the providers of spinal devices are adopting the strategy of providing these products through e-commerce and hospital pharmacies so that buyers can browse the products according to their needs. In October 2016, Stryker announced the launch of hand-held LITe BIO Delivery System to deliver bone graft material to spinal surgery sites. The system can be used for any type of spine fusion surgery.

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-2236

The report covers exhaustive analysis on

• Market Segments
• Market Dynamics
• Market Size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies involved
• Technology
• Value Chain

Regional analysis includes

• North America (U.S., Canada)
• Latin America (Mexico, Brazil, Rest Of Latin America)
• Western Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX, Rest Of Western Europe)
• Eastern Europe (Russia, Poland, Rest Of Eastern Europe)
• Asia Pacific Excluding Japan (China, India, ASEAN, Australia & New Zealand, Rest Of APEJ)
• Japan
• Middle East and Africa (GCC countries, S. Africa, N. Africa, Rest Of MEA)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/reports/brochure/rep-gb-2236

Spinal Device Market: Segmentation

The global spinal device market is classified on the basis of device type, end user and geography.

Based on device type, the global spinal device market is segmented into the following:

• Allografts
• Bridge
• Connector
• Plate Fixation System
• Drug Infusion system
• Electrosurgical
• Portals
• Others

Based on end user, the global spinal device market is segmented into the following:

• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Spinal Surgery Rehabilitation Centers

About Future Market Insights, Inc.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact Us:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

While life expectancy has increased tremendously in the past 50 years, industrialization and the dominance of the services sector in the developed world has given rise to new health problems like stress, obesity and high blood pressure. Obesity in particular is one of the biggest scourges of a modern lifestyle without any time (or inclination) to exercise and it can wreak havoc on the person’s health.

Obesity is a condition where a person is too heavy for their respective height and is calculated with the help of the body mass index (BMI). A BMI between 20 and 25 is considered normal, 25 or more is overweight, while 30 and above is called obese.

An obese person is far more likely to develop Type 2 Diabetes, have an unhealthy child, some kind of heart disease or even a stroke. An awareness of the dangers of obesity along with a focus on health has fuelled the demand for the home scales market.

People want to be able to measure their weight from the comfort of their homes and it is also used to motivate them to exercise more and drop those last few pounds. Continuous innovations with greater functionality or added features, increasing popularity of self-monitoring and a demand for high-tech electronics is expected to account for the continued demand of the home scales market.

Home Scales market Drivers

An aging population in the west, a sedentary, fast-paced lifestyle leaving no time to exercise, along with a greater awareness of the long term problems caused by obesity can be expected to drive the home scale market going forward. Added functionality and more features in home scales is also expected to help in no small measure.

An increased acceptance of digital body fat analysers in emerging markets will also provide a boost to the home scale market. They are worthy of mention since they measure body fat and help the person distinguish between fat and weight loss.

It is not just obese customers but even health-conscious people who will drive the demand for the home scales market in the medium to long term. A greater preference for privacy and the convenience of using these devices in the bedroom or bathroom will also contribute to the future prospects of the home scales market.

Request a Sample:

https://www.futuremarketinsights.com/reports/sample/rep-gb-2222

Home Scales market Key Regions

Europe is the largest home scales market, followed by North America in 2016. This is due to the presence of a post-industrial society where the services sector dominates leading to a sedentary lifestyle and also the prevalence of ready to eat, processed and unhealthy food. Germany, the USA and the UK are some of the largest individual home scales markets.

Asia Pacific accounts for the largest growth due to rapid urbanization, increased cases of obesity and also an increased awareness of advances in technology related to health and fitness. The key Asia Pacific markets include China, India, Japan and Korea.

Home Scales market Key Market Players

The key players in the home scales market are AWM Limited, Camry Electronic Ltd, Salter Housewares, Bonso Electronics, Johnson Measures and Weights Ltd, Omron Healthcare Co. Ltd., Leifheit AG, Guangdong Xiangshan Weighing Apparatus, and Tanita Corporation.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, types and applications.

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-2222

The report covers exhaustive analysis on

• Market Segments
• Market Dynamics
• Market Size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies involved
• Technology
• Value Chain

Regional analysis includes

• North America (U.S., Canada)
• Latin America (Mexico. Brazil)
• Western Europe (Germany, Italy, France, U.K, Spain)
• Eastern Europe (Poland, Russia)
• Asia Pacific (China, India, ASEAN, Australia & New Zealand)
• Japan
• Middle East and Africa (GCC, S. Africa, N. Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/reports/brochure/rep-gb-2222

About Future Market Insights, Inc.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact Us:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs